All doses through 10 mg/week fit in a single 1 mL syringe at this concentration
Insulin & Glucose-Related Research Through NAD-related and metabolic-signaling pathways, 5-Amino-1MQ has been investigated in research involving: Glucose-regulation pathways Insulin-related metabolic models Mitochondrial glucose-metabolism investigations Cellular-energy homeostasis research Oxidative-stress and inflammatory-signaling pathways The interaction between NAD, SIRT1, and AMPK-related pathways remains an ongoing area of metabolic research interest
Key index paths: Neuropathy, neuropathic main term subterm peripheral subterm by etiology (alcoholic, diabetic, drug-induced, hereditary, idiopathic, inflammatory, ischemic, toxic) Neuropathy, peripheral, diabetic see E08E13 with .40.49 Polyneuropathy main term subterms by etiology (alcoholic G62.1, critical illness G62.81, diabetic [see Diabetes, with neuropathy], drug-induced G62.0, hereditary G60.x, idiopathic G60.9, inflammatory G61.x, radiation G62.82, toxic G62.2) Syndrome, carpal tunnel G56.0- Syndrome, tarsal tunnel G57.5- Syndrome, Guillain-Barr G61.0 Neuropathy, CIDP G61.81 Disease, Charcot-Marie-Tooth G60.0 Meralgia paresthetica G57.1- Neuralgia, post-herpetic B02.29 (other PHN) or B02.22 (trigeminal) Degeneration, subacute combined G32.0 Dysautonomia G90.1 (familial), G90.09 (other idiopathic) Syndrome, Refsum G60.1 Coder Note When the index leads to see also Diabetes, with, neuropathy always confirm documentation of the specific type of diabetes (Type 1, Type 2, secondary, drug-induced) before selecting the E-code subcategory
Severe vitamin B12 deficiency can lead to memory loss, joint pain, and vision problems, among other complications
